<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02796625</url>
  </required_header>
  <id_info>
    <org_study_id>10017571</org_study_id>
    <nct_id>NCT02796625</nct_id>
  </id_info>
  <brief_title>Alpha as a Predictive Biomarker</brief_title>
  <acronym>APB</acronym>
  <official_title>Development of a Reliable Neurophysiological Pain Assessment Tool: Alpha as a Predictive Biomarker</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland, Baltimore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Purdue Pharma LP</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Maryland, Baltimore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will use non-invasive recordings of brain activity to measure pain as a&#xD;
      proxy to self-report. Participants will undergo testing for about 3 hours on two separate&#xD;
      days. The testing will involve experiencing painful heat.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neurophysiological investigations of pain have suggested that electroencephalograph (EEG)&#xD;
      measures of peak alpha frequency might provide a means of pain assessment. In healthy&#xD;
      subjects, increased peak alpha frequency is strongly correlated with pain self-reports after&#xD;
      exposure to acute noxious heat. Conversely, chronic pain patients compared to healthy control&#xD;
      display decreased peak alpha frequencies higher in alpha power. Measures of peak alpha&#xD;
      frequency also show a negative relationship with disease duration, suggesting that peak alpha&#xD;
      frequency may not only index ongoing pain but also disease progression. The overall aim is to&#xD;
      determine the predictive accuracy, reliability, and specificity of EEG alpha activity in&#xD;
      acute pain and a model of neuropathic pain in healthy subjects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2016</start_date>
  <completion_date type="Actual">July 2018</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak Alpha Frequency (Hz)</measure>
    <time_frame>pain-free and pain states at the baseline visit</time_frame>
    <description>The highest power of EEG-based alpha activity in the 8-12Hz frequency range, calculated using the center of gravity method.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alpha Wave Activity Reliability</measure>
    <time_frame>alpha activity at pain-free and pain states, assessed at a second visit following the first visit by at least 3 week</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Painful Stimuli</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be exposed to painful heat</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Painful Stimuli</intervention_name>
    <description>warm or painful heat administration</description>
    <arm_group_label>Painful Stimuli</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to speak, read, and write English&#xD;
&#xD;
          -  Between 21 and 44 years of age&#xD;
&#xD;
          -  Able to understand and willing to comply with all study procedures and is available&#xD;
             for the duration of the study&#xD;
&#xD;
          -  Free of an acute or chronic pain condition&#xD;
&#xD;
          -  Not history of psychiatric or neurologic condition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to undergo EEG, assessed on an individual basis&#xD;
&#xD;
          -  History of unstable major psychiatric disorder (self-report)&#xD;
&#xD;
          -  History of chronic pain (self-report)&#xD;
&#xD;
          -  More than 14 alcoholic drinks per week on average (self-report)&#xD;
&#xD;
          -  Active [within 6 months] substance or alcohol abuse (self-report and urine toxicology)&#xD;
&#xD;
          -  Use of opioids (self-report and urine toxicology)&#xD;
&#xD;
          -  History of major depressive disorder (self-report)&#xD;
&#xD;
          -  Pregnant or Lactating (women only), based on (self-report and urine test)&#xD;
&#xD;
          -  Anything that, in the opinion of the investigator, would place the subject at&#xD;
             increased risk or preclude the subject's full compliance with or completion of the&#xD;
             study&#xD;
&#xD;
          -  Uncontrolled (systolic blood pressure &gt; 175 mmHg or diastolic blood pressure &gt;105&#xD;
             mmHg) or unstable hypertension&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David A Seminowicz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland Dental School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Maryland School of Dentistry</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 25, 2016</study_first_submitted>
  <study_first_submitted_qc>June 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2016</study_first_posted>
  <results_first_submitted>May 4, 2021</results_first_submitted>
  <results_first_submitted_qc>July 19, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 11, 2021</results_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland, Baltimore</investigator_affiliation>
    <investigator_full_name>David Seminowicz</investigator_full_name>
    <investigator_title>Associate Professor, Department of Neural and Pain Sciences</investigator_title>
  </responsible_party>
  <keyword>EEG</keyword>
  <keyword>healthy subjects</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 6, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT02796625/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Painful Stimuli</title>
          <description>Participants will be exposed to painful heat&#xD;
Painful Stimuli: warm or painful heat administration</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="80"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Painful Stimuli</title>
          <description>Participants will be exposed to painful heat&#xD;
Painful Stimuli: warm or painful heat administration</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="61"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="61"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="61"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.8" lower_limit="21" upper_limit="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="61"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="61"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Peak Alpha Frequency (Hz)</title>
        <description>The highest power of EEG-based alpha activity in the 8-12Hz frequency range, calculated using the center of gravity method.</description>
        <time_frame>pain-free and pain states at the baseline visit</time_frame>
        <population>all participants with valid data</population>
        <group_list>
          <group group_id="O1">
            <title>Painful Stimuli</title>
            <description>Participants will be exposed to painful heat&#xD;
Painful Stimuli: warm or painful heat administration</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Alpha Frequency (Hz)</title>
          <description>The highest power of EEG-based alpha activity in the 8-12Hz frequency range, calculated using the center of gravity method.</description>
          <population>all participants with valid data</population>
          <units>frequency (Hz)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.04" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Alpha Wave Activity Reliability</title>
        <time_frame>alpha activity at pain-free and pain states, assessed at a second visit following the first visit by at least 3 week</time_frame>
        <population>Participants with data at visits 1 and 2</population>
        <group_list>
          <group group_id="O1">
            <title>Painful Stimuli</title>
            <description>Participants will be exposed to painful heat&#xD;
Painful Stimuli: warm or painful heat administration</description>
          </group>
        </group_list>
        <measure>
          <title>Alpha Wave Activity Reliability</title>
          <population>Participants with data at visits 1 and 2</population>
          <units>Spearman rho</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Painful Stimuli</title>
          <description>Participants will be exposed to painful heat&#xD;
Painful Stimuli: warm or painful heat administration</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="61"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="61"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. David Seminowicz</name_or_title>
      <organization>University of Maryland Baltimore</organization>
      <phone>14107063476</phone>
      <email>dseminowicz@umaryland.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

